克拉恋人

Lessons of Japanese militarism's aggression must forever serve as alarm: spokesperson_我的网站

A |     The devastation and tragedies brought by nuclear weapons should never repeat themselves, and the lessons of Japanese militarism's aggression and expansion must forever serve as an alarm, a Chinese foreign ministry spokesperson said Thursday.    Spokesperson Lin Jian made the remarks when answering a query regarding the 81st anniversary of the atomic bombing of Japan's Hiroshima, adding the Japanese side needs to face up to the concerns of the international community, and earnestly fulfill its nuclear non-proliferation obligations under international law.    On Aug. 6, 1945, the United States dropped the first atomic bomb on Hiroshima, accelerating the end of World War II. 81 years on, right-wing forces in Japan are gearing up to revive militarism. The Japanese authorities are rebuilding Japan's war machine, seeking to revise the three non-nuclear principles, and pursuing nuclear sharing with the U.S. side, even the possession of nuclear weapons.    The particular context of the nuclear explosions should all the more be remembered, Lin said, adding that right-wing forces in Japan have long been distorting historical facts, politically exploiting the nation's identity as a nuclear bombing victim for sympathy and deliberately downplaying Japan's invasion that killed and wounded tens of millions of people in Japan's neighboring countries, in an attempt to escape accountability for the war.    "More ironically, the Japanese authorities have been beefing up military buildup, seeking enhanced nuclear protection from the United States, and attempting to break free from the three non-nuclear principles," said Lin. He pointed out that a senior official at the Prime Minister's Office even clamored for Japan's independent nuclear armament, without even hiding the ambition for remilitarization.    This is a provocation to all peace-loving people in the world and reveals their contempt for historical justice, Lin said.    "This year marks the 80th anniversary of the start of the Tokyo Trials. The jury of history is still out and demands reverence from Japan," Lin said, adding the Japanese side should not once again stand before the court of history.                    。    　　两只热门概念股，双双发布股价异动公告。
　　受海外医药巨头默沙东与Moderna（莫德纳）合作研发的个性化mRNA抗癌疫苗intismeran的III期临床试验研究成功的消息影响，键凯科技（688356）于8月20日和8月21日连续“20cm”涨停。　　8月21日晚间，键凯科技披露异动公告称，经公司自查，公司目前生产经营活动一切正常。市场环境、行业政策没有发生重大调整，生产成本和销售等情况没有出现大幅波动，内部生产经营秩序正常。公司控股股东、实控人也不存在涉及公司应披露而未披露的重大信息。　　针对市场传闻情况，公告称，经公司自查，公司未直接向Moderna提供LNP核心原料。mRNA肿瘤疫苗的商业化对公司业务的影响主要体现在两个方面。　　第一是材料销售业务方面，2025年，公司LNP类产品收入约751.21万元，占公司当年营业收入的比例较小，约为2.36%。公司预计短期内LNP相关的产品销售业务不会对公司材料销售收入情况产生重大影响。　　第二是研发管线方面，公司与康希诺（688185）合作的针对胶质母细胞瘤的mRNA疫苗项目，以及公司自研的mRNA肿瘤疫苗项目，目前均处于临床前研究阶段，存在较大不确定性。公司与康希诺共同开发的三组分LNP递送系统ISL-3C-LNP目前已向第三方授权，由于授权方项目尚处在临床前早期研究阶段，也存在较大不确定性。

B | 　　证券时报记者注意到，键凯科技异动公告中所提到的康希诺，在8月21日晚间同样发布了异动公告。

C | 二级市场上，康希诺同样于8月20日和8月21日连续两个交易日“20cm”涨停。　　康希诺公告称，公司关注到近期市场上关于mRNA技术的发展。

D | mRNA平台是公司布局的技术平台之一，公司正在进行mRNA预防用疫苗及治疗性生物制品的开发，以及相关递送系统的开发。

E | 治疗领域方面，公司正在推进mRNA疫苗用于治疗胶质母细胞瘤、横纹肌肉瘤及宫颈癌等适应症的研发工作，以及InVivoCAR相关疗法的开发，目前均处于早期阶段。

F | 　　除此之外，康希诺强调，公司目前生产经营活动正常，内部经营秩序正常。

G | 公司及公司控股股东、实控人不存在应披露而未披露的重大事项。（文章来源：证券时报）。

Current article:http://www.lichuorenrenyitankanmeimu.cfd/kysyp38/20260826/3933.html

Published on:01:13:09